Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data
Go back to Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data| (NASDAQ: ABVX) | Delayed: 98.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.43 | 52 Week High | $ | |||
| Open | $98.43 | 52 Week Low | $ | |||
| Day High | $98.43 | P/E | N/A | |||
| Day Low | $98.43 | EPS | $ | |||
| Volume | 12,684 | |||||
